%0 Journal Article
%T Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study.
%A Brunetti B
%A Bacci B
%A Sarli G
%A Pancioni E
%A Muscatello LV
%J Animals (Basel)
%V 11
%N 4
%D Apr 2021 3
%M 33916691
%F 3.231
%R 10.3390/ani11041006
%X HER2 overexpression has been reported in various human and canine tumours. The aim of this study is to investigate the expression of HER2 protein in different histotypes of canine carcinomas in order to identify potential tumours that could benefit from the HER2-targeted therapy. Eighty-two (82) canine carcinomas (squamous cell, gastro-intestinal, rectal, pulmonary, prostatic, urothelial, and ovarian) from paraffin-embedded samp les were immunohistochemically evaluated. The degree of HER2 expression was scored based on the ASCO/CAP 2018 guidelines. Intestinal carcinomas were those with greater HER2 overexpression (3+) with 81% of positive cases, followed by 42% of rectal carcinomas and 28% of squamous cell carcinomas. These observations suggest that HER2 overexpression could be a driver in the oncogenesis of several types of canine carcinomas and lay the foundations for the identification of different types of canine carcinomas that could benefit from HER2-targeted therapy.